Shares of IMI plc (LON:IMI – Get Free Report) reached a new 52-week high on Wednesday . The company traded as high as GBX 1,811 ($23.06) and last traded at GBX 1,794.47 ($22.84), with a volume of 5875 shares. The stock had previously closed at GBX 1,803 ($22.95).
Analysts Set New Price Targets
IMI has been the subject of several recent analyst reports. Berenberg Bank restated a “buy” rating and issued a GBX 1,950 ($24.82) target price on shares of IMI in a research report on Monday, March 4th. Royal Bank of Canada reissued an “outperform” rating and issued a GBX 2,150 ($27.37) price objective on shares of IMI in a report on Thursday, February 29th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a GBX 1,850 ($23.55) target price on shares of IMI in a research note on Thursday, December 14th.
Check Out Our Latest Analysis on IMI
IMI Stock Performance
IMI Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, May 17th. Stockholders of record on Thursday, April 4th will be issued a GBX 19.20 ($0.24) dividend. The ex-dividend date of this dividend is Thursday, April 4th. This is a boost from IMI’s previous dividend of $9.10. This represents a dividend yield of 1.11%. IMI’s dividend payout ratio (DPR) is 3,010.75%.
IMI Company Profile
IMI plc, a specialist engineering company, designs and manufactures engineering products in the United Kingdom, Germany, rest of Europe, the United States of America, rest of the Americas, China, rest of Asia Pacific, the Middle East, and Africa. It operates through IMI Precision Engineering, IMI Critical Engineering, and IMI Hydronic Engineering segments.
Further Reading
- Five stocks we like better than IMI
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Real Estate Stocks to Buy on Commission Cuts
- Stock Market Upgrades: What Are They?
- Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
- Are Penny Stocks a Good Fit for Your Portfolio?
- Growing Twice as Fast as Tesla, XPeng is a Buy
Receive News & Ratings for IMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI and related companies with MarketBeat.com's FREE daily email newsletter.